COVID-19

Showing NaN - NaN of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)

Recruiting
  • COVID-19
  • +3 more
  • RQ-001
  • Placebo
  • Cullman, Alabama
  • +8 more
Sep 28, 2023

COVID-19, SARS-CoV-2 Trial in United States (VYD222, Normal saline)

Recruiting
  • COVID-19
  • SARS-CoV-2
  • Culver City, California
  • +15 more
Sep 8, 2023

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2 (Omi XBB.1.5))

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2 (Omi XBB.1.5)
  • Dublin, California
  • +14 more
Aug 10, 2023

COVID-19 Trial in United States (NVX-CoV2373 (5µg), NVX-CoV2601 (5µg), NVX-CoV2601(5µg))

Not yet recruiting
  • COVID-19
  • NVX-CoV2373 (5μg)
  • +6 more
  • Birmingham, Alabama
  • +47 more
Jul 2, 2023

COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)

Recruiting
  • COVID-19
  • mRNA-1283.222
  • mRNA-1273.222
  • Birmingham, Alabama
  • +209 more
Apr 13, 2023

COVID-19 Trial in Miami (NP-101, Placebo)

Recruiting
  • COVID-19
  • Miami, Florida
    L&A Morales Healthcare/ Enrique Villa, MD Principal Investigator
Mar 23, 2023

COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196
  • +3 more
  • Tucson, Arizona
  • +106 more
Mar 24, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • AZD7442
  • +2 more
  • Tucson, Arizona
  • +123 more
Mar 24, 2023

COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)

Completed
  • COVID-19
  • LY3819253
  • +2 more
  • Tucson, Arizona
  • +56 more
Mar 22, 2023

COVID-19 Trial in Miami (Sesderma LACTYFERRIN™ Forte and Sesderma ZINC Defense™, Placebo)

Not yet recruiting
  • COVID-19
  • Sesderma LACTYFERRIN™ Forte and Sesderma ZINC Defense™
  • Placebo
  • Miami, Florida
    Keralty Hospital Miami
Mar 22, 2023

COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)

Completed
  • COVID-19
  • VIR-7831
  • +2 more
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (MP0420, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Miami (CareSuperb COVID-19 Antigen Home Test Kit)

Recruiting
  • COVID-19
  • CareSuperb COVID-19 Antigen Home Test Kit
  • Miami, Florida
    L&A Morales Healthcare, Inc.
Mar 14, 2023

COVID-19, Influenza A, Influenza B Trial in Miami (MGC Health COVID-19 & Flu A+B Home Multi Test, MGC Health COVID-19 & Flu A+B

Recruiting
  • COVID-19
  • +2 more
  • MGC Health COVID-19 & Flu A+B Home Multi Test
  • MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o)
  • Miami, Florida
    L&A Morales Healthcare
Feb 15, 2023

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo)

Completed
  • COVID-19
  • Jasper, Alabama
  • +102 more
Jan 14, 2023

COVID-19 Trial in Worldwide (ensovibep, Placebo)

Terminated
  • COVID-19
  • Jasper, Alabama
  • +47 more
Dec 21, 2022

COVID-19 Trial in United States (nirmatrelvir, ritonavir)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +22 more
Jan 11, 2023

Influenza, Human, COVID-19 Trial in United States (bivalent BNT162b2 (original/Omi BA.4/BA.5), qIRV (22/23), QIV)

Recruiting
  • Influenza, Human
  • COVID-19
  • bivalent BNT162b2 (original/Omi BA.4/BA.5)
  • +2 more
  • Athens, Alabama
  • +18 more
Dec 22, 2022

COVID-19 Trial in Miami, Knoxville, Memphis (RT-PCR Test, Real-time PCR Test)

Recruiting
  • COVID-19
  • RT-PCR Test
  • Real-time PCR Test
  • Miami, Florida
  • +2 more
Dec 20, 2022

COVID-19 Trial in United States (Hemopurifier)

Terminated
  • COVID-19
  • Hemopurifier
  • Irvine, California
  • +8 more
Dec 16, 2022

COVID-19 Trial in Worldwide (AZD7442, Placebo)

Active, not recruiting
  • COVID-19
  • Birmingham, Alabama
  • +85 more
Nov 25, 2022

COVID-19, Cardiovascular Diseases, Cardiovascular Risk Factor Trial in Brazil, Mexico, United States (Cannabidiol,

Terminated
  • COVID-19
  • +2 more
  • Cannabidiol, pharmaceutically produced with < 5 ppm THC
  • Placebo
  • Phoenix, Arizona
  • +19 more
Dec 12, 2022

COVID-19 Trial in United States (EDP-235, Placebo)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +20 more
Dec 6, 2022